The Cancer Letter

Inside information on cancer research and drug development

Vol.
37
No.
17
April 29, 2011Apr 29, 2011
Free
DOWNLOAD THE PDF

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent

Henschke Responds To Questions from The New York Times

Raymond Weiss Reviews Confidential Report on I-ELCAP

Login

Looking for IP Login?